<DOC>
	<DOC>NCT00633568</DOC>
	<brief_summary>The purpose of the present trial is to assess if induction concurrent chemoradiotherapy followed by consolidation chemotherapy will improve survival in comparison with the same chemotherapy given as induction followed by consolidation concurrent chemoradiotherapy.</brief_summary>
	<brief_title>Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histological or cytological diagnosis of nonsmall cell carcinoma of the lung Initially unresectable nonmetastatic stage III disease Availability for participating in the detailed followup of the protocol Presence of an evaluable or measurable lesion Written informed consent No functional or anatomical contraindication to chest irradiation Prior treatment with chemotherapy, radiotherapy or surgery Performance status &lt; 60 on the Karnofsky scale History of prior malignant tumour, except nonmelanoma skin cancer or in situ carcinoma of the cervix or cured malignant tumour (more than 5 year diseasefree interval) Neutrophils &lt; 2,000/mm³ Platelet cells &lt; 100,000/mm3 Serum bilirubin &gt; 1.5 mg/100 ml Hepatic disease contraindicating the administration of docetaxel and/or GOT or GPT ≥ 2.5x the normal value and/or alkaline phosphatase ≥ 5x the normal value Serum creatinine &gt; 1.5 mg/100 ml and/or creatinine clearance &lt; 60 ml/min Recent myocardial infarction (less than 3 months prior to date of diagnosis) or uncontrolled angina pectoris Congestive cardiac failure or cardiac arrhythmia requiring medical treatment Uncontrolled infectious disease Symptomatic polyneuropathy Auditive impairment contraindicating cisplatin administration Serious medical or psychological factors which may prevent adherence to the treatment schedule Malignant pleural or pericardial effusion Homolateral supraclavicular lymph node excepting upper lobe lesion Heterolateral supraclavicular lymph node Known hypersensitivity to docetaxel or cisplatin Pregnancy or for premenopausal patient, incapacity to use adequate contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Non-small cell lung carcinoma</keyword>
	<keyword>Concomitant radiochemotherapy</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Unresectable stage III non-small cell lung carcinoma</keyword>
</DOC>